Results
|
14921.
|
|
|
14922.
|
|
|
14923.
|
|
|
14924.
|
|
|
14925.
|
|
|
14926.
|
|
|
14927.
|
|
|
14928.
|
|
|
14929.
|
|
|
14930.
|
|
|
14931.
|
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα. [electronic resource] by
- Chen, George G
- Leung, Jackie
- Liang, Nian Ci
- Li, Li
- Wu, Kefeng
- Chan, Ursula P F
- Leung, Billy C S
- Li, Mingyue
- Du, Jing
- Deng, Yi Feng
- Gong, Xianling
- Lv, Yingnian
- Chak, Ernest C W
- Lai, Paul B S
Producer: 20130404
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
14932.
|
|
|
14933.
|
|
|
14934.
|
|
|
14935.
|
|
|
14936.
|
|
|
14937.
|
|
|
14938.
|
|
|
14939.
|
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors. [electronic resource] by
- Takahashi, Toshiaki
- Boku, Narikazu
- Murakami, Haruyasu
- Naito, Tateaki
- Tsuya, Asuka
- Nakamura, Yukiko
- Ono, Akira
- Machida, Nozomu
- Yamazaki, Kentaro
- Watanabe, Junichiro
- Ruiz-Garcia, Ana
- Imai, Keiji
- Ohki, Emiko
- Yamamoto, Nobuyuki
Producer: 20130404
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
14940.
|
|